1.Learning Objective 1: At the end of the presentation, attendees will be able to identify the three FDA approved non-invasive neuromodulation devices for headache

  • Learning Objective 2: At the end of the presentation attendees will be able to prescribe each of the three devices for appropriate indications
  • Learning Objective 3: At the end of the presentation, attendees will be acquainted with the current neuromodulation devices in development for headache
Session date: 
Tuesday, July 25, 2017 - 8:00am to 9:00am
Speaker Name: 
Stewart J. Tepper, MD
Location: 
NorthShore - Evanston
Evanston, IL 60201
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.